Rejuvenation Technologies, co-founded by John Ramunas (CEO) and Glenn Markov (COO), is developing RTI-LNG1, a treatment addressing telomere attrition, particularly for Idiopathic pulmonary fibrosis. The company aims to rewind the body’s molecular aging clocks, leveraging telomere extension to combat age-related diseases.
×
Rejuvenation Technologies � RTI-LNG1 (IPF)
© 2021 - Lifespan Extension Advocacy Foundation - LIFESPAN2023
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.
Powered by MMD